Pregabalin Intermediate : R-(-)3-Carbamoylmethyl-5-Methyl-Hexanoic acid [ R- CMH ] | Cas no 181289-33-8
CAS No.
181289-33-8
End API
Pregabalin
Vilayat Pharma is the largest Pregabalin Intermediate manufacturer and exporter. Pregabalin Intermediate is representated with Chemical Name of R-(-)-3-Carbamoylmethyl-5-methyl-hexanoic acid with Cas no 181289-33-8. Vilayat pharma offers this product with consistent quality and large batch size from its cGMP manufacturing site based out of Gujarat to its global customers.
CAS number: 181289-33-8
Chemical Name also known as:
- R-(-)-3-Carbamoylmethyl-5-methyl-hexanoic acid
R-(-)-3-Carbamoylmethyl-5-methyl-hexanoic acid is a chemical intermediate used to manufacture the anticonvulsant drug Pregabalin. It is a chiral molecule. This intermediate is synthesized and then used to produce Pregabalin, which is used to treat neuropathic pain and seizures
Vilayat Pharma is one of the largest Pregabalin intermediate manufacturer located in Gujarat that offers a huge portfolio of drug intermediates for its partners. With over 55 years of experience in the chemical field, Vilayat, part of the Family Owned Colourtex Group, has cultivated a strong reputation for its sustainable and competitive manufacturing of pharma chemicals and intermediates. They supply these products to reputable multinational corporations (MNCs) and innovator companies, reflecting their rich and diverse background.
As an ISO 9001: 2015 certified company with GMP certification, we take it upon ourselves to ensure we adhere to strict quality and regulatory parameters. We continually develop quality first products for all our partners as a customer-oriented and R&D-driven organization.
Vilayat Pharma chemical expertise and vast experience in manufacturing of these range of intermediates. Vilayat pharma is able to effectively manage large volume manufacturing with ; control over quality with utmost safety. Please check out our core capabilities here.
Disclaimer: Vilayat Pharma respects patent laws and conventions of Chemicals as applicable in different countries. Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions. The products covered by patent are not commercially offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.